58 Week Open-Label Trial of Tavapadon in PD (TemPo-4 Trial)
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Cerevel Therapeutics
Start Date
October 13, 2020
End Date
June 30, 2025
Administered By
Neurology, Movement Disorders
Awarded By
Cerevel Therapeutics
Start Date
October 13, 2020
End Date
June 30, 2025